- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (376)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1785)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2024 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Soldera J. Navigating treatment resistance: Janus kinase inhibitors for ulcerative colitis. World J Clin Cases 2024; 12(24): 5468-5472 [PMID: PMC11269992 DOI: 10.12998/wjcc.v12.i24.5468] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v12/i24/5468.htm |
| Number | Citing Articles |
| 1 |
Tugrul Purnak, Atilla Ertan. Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease. Journal of Clinical Medicine 2024; 13(23): 7026 doi: 10.3390/jcm13237026
|
| 2 |
Maryia Zhdanava, Sabree Burbage, Todor I. Totev, Sumesh Kachroo, Lilian Diaz, Bridget Godwin, Patrick Lefebvre, Dominic Pilon. Real-world prevalence of potential drug-drug interactions associated with oral advanced therapies indicated for ulcerative colitis. Current Medical Research and Opinion 2025; : 1 doi: 10.1080/03007995.2025.2465649
|
| 3 |
|